Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 100
Age Group: 19 Years to 70 Years (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Other|Time Perspective: Prospective
Study ID Numbers: CURE001
Study First Received: May 2, 2016
Last Updated: March 23, 2017
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
CD 74 and VEGF detection effect on response to treatment
Sponsors and Collaborators:
Ain Shams University
Website Link: https://ClinicalTrials.gov/show/NCT02761863